Atlas Trials

Study to Determine the Effect of Itraconazole on the Pharmacokinetics of Rilapladib (SB659032) in Healthy Volunteers

Clinical trial NCT02130661 · WITHDRAWN

Trial details

NCT number
NCT02130661
Sponsor
GlaxoSmithKline
Status
WITHDRAWN
Phase
Phase 1
Study type
INTERVENTIONAL
Alzheimer's Disease
Start date
2017-10-01
Primary completion
2018-01-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.